生物
新德里
抗生素
细菌
多重耐药
微生物学
抗药性
生物技术
遗传学
医学
病理
大都市区
作者
Xiaoxia Gu,Mengzhu Zheng,Lixia Chen,Hua Li
标识
DOI:10.1016/j.micres.2022.127079
摘要
New Delhi metallo-β-lactamase-1 (NDM-1) can hydrolyze almost all antibiotics of the β-lactam group, resulting in the generation of multidrug resistant bacteria. Besides its broad hydrolytic activity, pathogens expressing NDM-1 often harbor other antibiotic-resistant genes, further promoting the pervasion of multi-resistant clinical isolates and making clinically available drugs scantier. Despite the urgent need for NDM-1 inhibitors, there is no approved drug in clinic. Here, we summarize NDM-1 inhibitors developed since 2018, classify these compounds by chemical scaffolds, and propose some inconsistencies and notable problems among these studies, which are expected to benefit future research.
科研通智能强力驱动
Strongly Powered by AbleSci AI